NOK 223
Key Takeaways
Risk factor
Poor trading liquidity
Profitability factor
Very strong margins and returns
About
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITD
Target Price
The average target price of MEDI.OL is 299 and suggests 34% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
